BIOPX Mutual Fund

BIOPX Mutual Fund

NAV$61.47
See how much of BIOPX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Mar 31, 2026

Net Assets
-
Expense Ratio
1.31%
Dividend Yield (Current)
4.05%
Holdings
50
Inception Date
Feb 29, 2000
Fund Family
Baron Funds
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+5.08%
1 Year+11.69%
3 Year+22.49%
5 Year+8.79%
10 Year+20.35%

Asset Allocation

Stocks: 100.00%
See how much of BIOPX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report is $25, once. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
NVDANvidia Corp.13.26%
SPCXSpace Exploration Technologies6.61%
AVGOBroadcom Inc6.28%
AMZNAmazon.Com Inc6.25%
ARKXSpace Exploration Tech Class A6.03%
Top 10 Concentration: 58.88%Report Date: Mar 31, 2026
Download all 50 holdings for BIOPX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
4.05%
Frequency
Annually
Latest Distribution
$3.60
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

BIOPX Mutual Fund Overview

BIOPX Mutual Fund (Baron Opportunity Fund Retail Class) is managed by Baron Funds. BIOPX expense ratio is 1.31%, holding 50 positions across sectors including Information Technology, Consumer Discretionary, Communication Services. Inception date: 2000-02-29.

BIOPX performance shows a YTD return of 5.08%. The 1-year return is 11.69% and the 5-year return is 8.79%. BIOPX dividend yield stands at 4.05%, paid annually.

BIOPX top holdings include Nvidia Corp. (13.3%), Space Exploration Technologies (6.6%), Broadcom Inc (6.3%), Amazon.Com Inc (6.3%), Space Exploration Tech Class A (6.0%). Go to all BIOPX holdings, BIOPX sectors, or BIOPX dividends.

BIOPX can be compared against other funds. Use BIOPX overlap to find shared positions, or BIOPX vs another fund for a side-by-side view. BIOPX alternatives are available via the screener, along with tax-loss harvesting opportunities.